Episode Thumbnail
Episode 1  |  27:11 min

How Sonavex Went from Concept to FDA Clearance in Just 3 Years

Episode 1  |  27:11 min  |  04.07.2019

How Sonavex Went from Concept to FDA Clearance in Just 3 Years

00:00
00:00
This is a podcast episode titled, How Sonavex Went from Concept to FDA Clearance in Just 3 Years. The summary for this episode is: How do medical device companies approach the “scaries” related to quality and guidance regulations without breaking the bank? Today’s guest is David Narrow, CEO and founder of Sonavex, a medical device company that offers automated ultrasound solutions. David played a key role in helping Sonavex grow by going from a startup to developing an idea to launching a product in just three years. David shares how to successfully fundraise for seed and Series A rounds, implement a quality management system (QMS), and achieve regulatory pre-submission and 510(k) clearance. Some of the highlights of the show include: - Cost-effective and efficient options: Bring in somebody to set up paper-based QMS or select electronic QMS with expert guidance on implementation and maintenance procedures. - Sonavex sought buy-in from FDA early on and put together a thorough pre-submission package to gain confidence and move forward with its product. - Pre-submission process is a time-intensive but worthwhile paperwork burden. The information gathered is imperative and prepares you for 510(k) submission. - Once on the 510(k) path, you’re usually committed to various activities, including expensive verification testing. Pre-submission can prevent need for re-testing. - Sonavex and TMCx strive to understand reimbursement, healthcare economics, and other key facets. Do good and help each other through resources. - David’s Advice: Identify what you don’t know, get support from resources/experts, obtain experience, take calculated risks, etc. - When fundraising, figure out and find an investor who is the right fit based on the purpose and stage of your company. - David describes what to look forward to at Sonavex, such as starting a limited release of its first product and pursuing initial market applications.
Takeaway 1 | 00:19 MIN
Experienced Professionals Guide Implementation of eQMS
Takeaway 2 | 00:34 MIN
Great QMS Vendor Relationship Gives Companies a Competitive Edge
Takeaway 3 | 00:45 MIN
Key Elements of a Company's Success
How do medical device companies approach the “scaries” related to quality and guidance regulations without breaking the bank? Today’s guest is David Narrow, CEO and founder of Sonavex, a medical device company that offers automated ultrasound solutions. David played a key role in helping Sonavex grow by going from a startup to developing an idea to launching a product in just three years. David shares how to successfully fundraise for seed and Series A rounds, implement a quality management system (QMS), and achieve regulatory pre-submission and 510(k) clearance. Some of the highlights of the show include: - Cost-effective and efficient options: Bring in somebody to set up paper-based QMS or select electronic QMS with expert guidance on implementation and maintenance procedures. - Sonavex sought buy-in from FDA early on and put together a thorough pre-submission package to gain confidence and move forward with its product. - Pre-submission process is a time-intensive but worthwhile paperwork burden. The information gathered is imperative and prepares you for 510(k) submission. - Once on the 510(k) path, you’re usually committed to various activities, including expensive verification testing. Pre-submission can prevent need for re-testing. - Sonavex and TMCx strive to understand reimbursement, healthcare economics, and other key facets. Do good and help each other through resources. - David’s Advice: Identify what you don’t know, get support from resources/experts, obtain experience, take calculated risks, etc. - When fundraising, figure out and find an investor who is the right fit based on the purpose and stage of your company. - David describes what to look forward to at Sonavex, such as starting a limited release of its first product and pursuing initial market applications.

More Episodes

Improving Outcomes and Reducing Costs with an Intelligent Surgical Medical Device

Elevating True Quality with SaMD for Early Cancer Detection and Treatment

A Firsthand Account of the Origins and Outcomes of FDA's Case For Quality and MDDAP

Eliminating Subjectivity And Guesswork With A Modernized Solution To Detecting Ear Infections

Creating a Culture of Quality at your MedTech Company

Improving the Colon Cancer Screening Experience